Dr. Lublin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
1st Floor
New York, NY 10029Phone+1 212-241-6854Fax+1 212-241-4460
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1975 - 1976
Zucker School of Medicine at Hofstra/NorthwellResidency, Neurology, 1974 - 1975- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1973 - 1974
Jacobi Medical Center/Albert Einstein College of MedicineInternship, Internal Medicine, 1972 - 1973
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1972
Certifications & Licensure
NJ State Medical License 2020 - 2025
NY State Medical License 1973 - 2025
PA State Medical License 1976 - 2024- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top Doctors: New York Metro Area Castle Connolly, 2003-2018
- America's Top Doctors Castle Connolly, 2002-2018
- New York Magazine: Top Doctors Castle Connolly, 2002-2008, 2015
- Join now to see all
Clinical Trials
- Combination Therapy in Patients With Relapsing-Remitting Multiple Sclerosis (MS)CombiRx Start of enrollment: 2005 Jan 01
- Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis Start of enrollment: 2002 Dec 01
- Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks Start of enrollment: 2003 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 4143 citationsDiagnosis of multiple sclerosis: 2017 revisions of the McDonald criteriaAlan J. Thompson, Brenda Banwell, Frederik Barkhof, William M. Carroll, Timothy Coetzee
The Lancet. Neurology. 2017-12-21 - 58 citationsSafety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial.Bruce A.C. Cree, Gary Cutter, Jerry S. Wolinsky, M. S. Freedman, Giancarlo Comi
The Lancet. Neurology. 2020-12-01 - 197 citationsClinical Course of Multiple Sclerosis.Sylvia Klineova, Fred D. Lublin
Cold Spring Harbor Perspectives in Medicine. 2018-09-01
Press Mentions
Two Mount Sinai Experts Receive Honors from the National Multiple Sclerosis SocietySeptember 16th, 2021- MS Treatment Baby-Boom: Quadruplets!May 6th, 2021
- Experts Clarify Concepts of MS States to Improve Patient Care, Clinical TrialsJune 15th, 2020
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
